Ritter M - Search Results

1

Medium-term Oncological Efficacy and Patient-reported Outcomes After Focal High-intensity Focused Ultrasound: The FOXPRO Trial.

Westhoff N, Ernst R, Kowalewski KF, Derigs F, Neuberger M, Nörenberg D, Popovic ZV, Ritter M, Stephan Michel M, von Hardenberg J. Westhoff N, et al. Among authors: ritter m. Eur Urol Focus. 2023 Mar;9(2):283-290. doi: 10.1016/j.euf.2022.10.006. Epub 2022 Nov 4. Eur Urol Focus. 2023. PMID: 36344395

2

Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center.

Krausewitz P, Büttner T, von Danwitz M, Weiten R, Cox A, Klümper N, Stein J, Luetkens J, Kristiansen G, Ritter M, Ellinger J. Krausewitz P, et al. Among authors: ritter m. BMC Urol. 2024 Mar 26;24(1):71. doi: 10.1186/s12894-024-01460-5. BMC Urol. 2024. PMID: 38532370 Free PMC article.

3

Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study.

Krausewitz P, Fostitsch D, Weiten R, Kluemper N, Stein J, Luetkens J, Kristiansen G, Ellinger J, Ritter M. Krausewitz P, et al. Among authors: ritter m. World J Urol. 2023 Jan;41(1):19-25. doi: 10.1007/s00345-022-04230-w. Epub 2022 Dec 7. World J Urol. 2023. PMID: 36477403 Free PMC article.

4

Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution.

Cox A, Klümper N, Stein J, Sikic D, Breyer J, Bolenz C, Roghmann F, Erben P, Wirtz RM, Wullich B, Ritter M, Hölzel M, Schwamborn K, Horn T, Gschwend J, Hartmann A, Weichert W, Erlmeier F, Eckstein M. Cox A, et al. Among authors: ritter m. Eur Urol. 2024 Apr;85(4):328-332. doi: 10.1016/j.eururo.2023.03.020. Epub 2023 Apr 6. Eur Urol. 2024. PMID: 37031005 Free article.

5

On-treatment Modified Glasgow Prognostic Score Provides Predictive Information Complementary to Radiological Staging in Metastatic Urothelial Carcinoma on Immunotherapy.

Saal J, Grünwald V, Bald T, Ritter M, Brossart P, Tomita Y, Hartmann A, Hölzel M, Eckstein M, Klümper N. Saal J, et al. Among authors: ritter m. Eur Urol Oncol. 2024 Jun;7(3):328-331. doi: 10.1016/j.euo.2023.11.005. Epub 2023 Nov 22. Eur Urol Oncol. 2024. PMID: 37996277

6

DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men-study protocol for a randomized trial.

Krausewitz P, Bundschuh RA, Gaertner FC, Essler M, Attenberger U, Luetkens J, Kristiansen G, Muders M, Ohlmann CH, Hauser S, Ellinger J, Ritter M. Krausewitz P, et al. Among authors: ritter m. Trials. 2023 Mar 6;24(1):167. doi: 10.1186/s13063-023-07197-0. Trials. 2023. PMID: 36879271 Free PMC article.

7

Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.

Stein J, Krappe E, Kremer A, Cronauer MV, Essler M, Cox A, Klümper N, Krausewitz P, Ellinger J, Ritter M, Kristiansen G, Majores M. Stein J, et al. Among authors: ritter m. J Cancer Res Clin Oncol. 2024 Feb 4;150(2):76. doi: 10.1007/s00432-023-05579-0. J Cancer Res Clin Oncol. 2024. PMID: 38310601 Free PMC article.

8

Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers.

von Danwitz M, Klümper N, Bernhardt M, Cox A, Krausewitz P, Alajati A, Kristiansen G, Ritter M, Ellinger J, Stein J. von Danwitz M, et al. Among authors: ritter m. Cancers (Basel). 2023 Mar 21;15(6):1890. doi: 10.3390/cancers15061890. Cancers (Basel). 2023. PMID: 36980776 Free PMC article.

9

Emotion-centered versus fact-centered medical information to alleviate pain and anxiety in prostate biopsy: A randomized trial.

Krausewitz P, Schmeller H, Spitzer C, Ellinger J, Ritter M, Petrowski K, Conrad R. Krausewitz P, et al. Among authors: ritter m. Prostate. 2024 Mar;84(4):389-394. doi: 10.1002/pros.24659. Epub 2023 Dec 20. Prostate. 2024. PMID: 38116739 Clinical Trial.

10

Multicenter evaluation of complex urinary diversion for renal transplantation: outcomes of complex surgical solutions.

Flegar L, Huber J, Putz J, Thomas C, Apel H, Wullich B, Friedersdorff F, Fechner G, Ritter M, Kernig K, Weigand K, Heynemann H, Stöckle M, Zeuschner P; Working Group Kidney Transplantation of the German Association of Urology. Flegar L, et al. Among authors: ritter m. World J Urol. 2024 Apr 17;42(1):239. doi: 10.1007/s00345-024-04934-1. World J Urol. 2024. PMID: 38630278 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,845 results

Search Page